Are Wall Street Analysts Bullish on Zoetis Stock?

With a market cap of $77.6 billion, Zoetis Inc. (ZTS) is a global leader in animal health, specializing in the discovery, development, and commercialization of medicines, vaccines, and diagnostics for both livestock and companion animals. With a diverse product portfolio spanning parasiticides, anti-infectives, dermatology, and medicated feed additives, the company serves veterinarians, livestock producers, and pet owners worldwide.

Shares of the animal health company have underperformed the broader market over the past 52 weeks. ZTS has decreased 12.9% over this time frame, while the broader S&P 500 Index ($SPX) has gained 20.7%. However, ZTS stock has risen 5.5% on a YTD basis, outperforming SPX's 3.1% YTD gain.